Young-Hwue Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Young-Hwue Kim has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Jae-Kon Ko
Division of Pediatric Cardiology, Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
5 shared publications- Jeong Jin Yu
University of Ulsan College of Medicine
5 shared publications Hong Ki Ko
Department of Pediatrics, Ajou University Hospital, Ajou University School of Medicine, Suwon, Korea
3 shared publications- Jae Suk Baek
Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine , Seoul
3 shared publications Jeong Jin Yu
Division of Pediatric Cardiology, Asan Medical Center, University of Ulsan College of Medicine
3 shared publications- In-Sook Park
University of Ulsan College of Medicine, Asan Medical Center
2 shared publications
Latest Publications
- Open Access
- 30 June 2023
- Published by Korean Society of Kawasaki Disease in Kawasaki Disease
- Vol. 1 (1)
Plasma Exchange Treatment in Five Kawasaki Disease Patients Unresponsive to Intravenous Immunoglobulin
The efficacy of high-dose intravenous immunoglobulin (IVIG) treatment for acute-stage Kawasaki disease patients has become widely recognized. However, in the case of refractory Kawasaki disease, alternative treatment should be considered to prevent coronary artery abnormality (CAA). Here, we present several cases of Kawasaki disease in children treated with plasma exchange (PE). We retrospectively reviewed the medical records of 5 subjects who had been unresponsive to IVIG treatments and treated with PE consecutively. The fever subsided and the other clinical manifestations were improved after PE in all cases. In two cases, giant coronary artery aneurysms were detected on echocardiographic follow-up study. PE should be a method with promising efficacy and might be considered in refractory Kawasaki disease patients for whom other treatment options have failed.
- 30 June 2023
- Published by Korean Society of Kawasaki Disease in Kawasaki Disease
- Vol. 1 (1)
Open AccessPlasma Exchange Treatment in Five Kawasaki Disease Patients Unresponsive to Intravenous Immunoglobulin
The efficacy of high-dose intravenous immunoglobulin (IVIG) treatment for acute-stage Kawasaki disease patients has become widely recognized. However, in the case of refractory Kawasaki disease, alternative treatment should be considered to prevent coronary artery abnormality (CAA). Here, we present several cases of Kawasaki disease in children treated with plasma exchange (PE). We retrospectively reviewed the medical records of 5 subjects who had been unresponsive to IVIG treatments and treated with PE consecutively. The fever subsided and the other clinical manifestations were improved after PE in all cases. In two cases, giant coronary artery aneurysms were detected on echocardiographic follow-up study. PE should be a method with promising efficacy and might be considered in refractory Kawasaki disease patients for whom other treatment options have failed.
- Open Access
- 25 August 2021
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 85 (9) , 1527-1534
Procedural Predictors and Outcomes of Percutaneous Secundum Atrial Septal Defect Closure in Children Aged <6 Years
Background:Percutaneous atrial septal defect (ASD) closure is the treatment of choice for patients with a suitable ASD anatomy; however, the procedural characteristics and outcomes in children aged Methods and Results:Patients from a single center between 2006 and 2018 (n=407) were retrospectively evaluated. There were 265 (65.1%) female patients. The median age at the time of the procedure and ASD size were 3.4 (0.9–5.9) years and 13.3 (3.8–27.0) mm, respectively. Medical records and echocardiographic images were analyzed. A challenging case was indicated by the use of non-conventional techniques. The procedure was completed in 399 patients (98.0%). Post-procedural acute complications occurred in 5 patients, including 1 with device embolization. Two patients underwent surgical device removal. During the follow up (30.3 [3.6–140.8] months), aggravated mitral regurgitation occurred in 5 patients. A multivariate logistic regression revealed large-sized ASD as a predictor of procedural failure (odds ratio=1.828, 95% confidence interval: 1.139–2.934, P=0.012) and challenging cases (odds ratio=1.371, 95% confidence interval: 1.180–1.593, PConclusions:Percutaneous ASD closure is feasible and safe in children aged <6 years; however, patients with large-sized ASD are at high risk of procedural failure and becoming a challenging case.
- 25 August 2021
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 85 (9) , 1527-1534
Open AccessProcedural Predictors and Outcomes of Percutaneous Secundum Atrial Septal Defect Closure in Children Aged <6 Years
Background:Percutaneous atrial septal defect (ASD) closure is the treatment of choice for patients with a suitable ASD anatomy; however, the procedural characteristics and outcomes in children aged Methods and Results:Patients from a single center between 2006 and 2018 (n=407) were retrospectively evaluated. There were 265 (65.1%) female patients. The median age at the time of the procedure and ASD size were 3.4 (0.9–5.9) years and 13.3 (3.8–27.0) mm, respectively. Medical records and echocardiographic images were analyzed. A challenging case was indicated by the use of non-conventional techniques. The procedure was completed in 399 patients (98.0%). Post-procedural acute complications occurred in 5 patients, including 1 with device embolization. Two patients underwent surgical device removal. During the follow up (30.3 [3.6–140.8] months), aggravated mitral regurgitation occurred in 5 patients. A multivariate logistic regression revealed large-sized ASD as a predictor of procedural failure (odds ratio=1.828, 95% confidence interval: 1.139–2.934, P=0.012) and challenging cases (odds ratio=1.371, 95% confidence interval: 1.180–1.593, PConclusions:Percutaneous ASD closure is feasible and safe in children aged <6 years; however, patients with large-sized ASD are at high risk of procedural failure and becoming a challenging case.
- Open Access
- 15 February 2021
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 64 (2) , 49-59
Pediatric heart transplantation: how to manage problems affecting long-term outcomes?
Since the initial International Society of Heart Lung Transplantation registry was published in 1982, the number of pediatric heart transplantations has increased markedly, reaching a steady state of 500–550 transplantation annually and occupying up to 10% of total heart transplantations. Heart transplantation is considered an established therapeutic option for patients with end-stage heart disease. The long-term outcomes of pediatric heart transplantations were comparable to those of adults. Issues affecting long-term outcomes include acute cellular rejection, antibody-mediated rejection, cardiac allograft vasculopathy, infection, prolonged renal dysfunction, and malignancies such as posttransplant lymphoproliferative disorder. This article focuses on medical issues before pediatric heart transplantation, according to the Korean Network of Organ Sharing registry and as well as major problems such as graft rejection and cardiac allograft vasculopathy. To reduce graft failure rate and improve long-term outcomes, meticulous monitoring for rejection and medication compliance are also important, especially in adolescents.
- 15 February 2021
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 64 (2) , 49-59
Open AccessPediatric heart transplantation: how to manage problems affecting long-term outcomes?
Since the initial International Society of Heart Lung Transplantation registry was published in 1982, the number of pediatric heart transplantations has increased markedly, reaching a steady state of 500–550 transplantation annually and occupying up to 10% of total heart transplantations. Heart transplantation is considered an established therapeutic option for patients with end-stage heart disease. The long-term outcomes of pediatric heart transplantations were comparable to those of adults. Issues affecting long-term outcomes include acute cellular rejection, antibody-mediated rejection, cardiac allograft vasculopathy, infection, prolonged renal dysfunction, and malignancies such as posttransplant lymphoproliferative disorder. This article focuses on medical issues before pediatric heart transplantation, according to the Korean Network of Organ Sharing registry and as well as major problems such as graft rejection and cardiac allograft vasculopathy. To reduce graft failure rate and improve long-term outcomes, meticulous monitoring for rejection and medication compliance are also important, especially in adolescents.
- Open Access
- 1 January 2021
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 51 (1) , 83-93
Growth Pattern of the Neo-Aorta after Arterial Switch Operation during Childhood
Korean Circulation Journal 대한심장학회지 순환기 Cha SG, et al. Korean Circ J. 2021 Jan;51(1):83-93. https://doi.org/10.4070/kcj.2020.0249
- 1 January 2021
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 51 (1) , 83-93
Open AccessGrowth Pattern of the Neo-Aorta after Arterial Switch Operation during Childhood
Korean Circulation Journal 대한심장학회지 순환기 Cha SG, et al. Korean Circ J. 2021 Jan;51(1):83-93. https://doi.org/10.4070/kcj.2020.0249
- Open Access
- 29 December 2018
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 16 (1) , 83
Coronary artery status of patients with transient fever 24–36 h after first IVIG infusion did not differ from that seen in responsive patients
Current management guidelines for patients with Kawasaki disease (KD) differ in their recommendations for fever observation times when determining resistance to initial intravenous immunoglobulin (IVIG). This retrospective study assessed coronary artery status in patients with transient fever 24–36 h after the completion of a first IVIG infusion. Children with KD treated with IVIG between January 2006 and February 2017 were included. Subjects were divided into three groups according to response following the completion of initial IVIG treatment (Group 1, no fever after 24 h; Group 2, transient fever at 24–36 h; Group 3, others). A total of 879 children were evaluated (Group 1, n = 663; Group 2, n = 54; Group 3, n = 162). During the subacute phase, the left main coronary artery (LMCA) diameter z score in both groups was significantly lower than that in Group 3 (Group 1: 1.02, Group 2: 0.87, Group 3: 1.24; Group 1 vs 2, P = 0.298; Group 1 vs 3, P = 0.025; Group 2 vs 3, P = 0.042); similar results were seen with the left anterior descending coronary artery (LAD) diameter z score (Group 1: 0.64, Group 2: 0.38, Group 3: 0.98; Group 1 vs 2, P = 0.083; Group 1 vs 3, P = 0.001; Group 2 vs 3, P = 0.004). The coronary artery (CA) status also did not differ between Groups 1 and 2 during the convalescent phase (z score of LMCA was 0.70 in Group 1 and 0.74 in Group 2, P = 0.790; z score of LAD was 0.42 and 0.46 respectively, P = 0.796; z score of right CA was 0.07 and 0.00 respectively, P = 0.630). A multivariate logistic regression analysis identified total bilirubin level (OR, 2.472; 95% CI, 1.284–4.762; P = 0.007) as the only significant predictor of persisting fever over 36 h in patients with fever 24 h after the completion of initial IVIG. The CA status of patients with transient fever 24–36 h after the first IVIG infusion did not differ from that seen in responsive patients.
- 29 December 2018
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 16 (1) , 83
Open AccessCoronary artery status of patients with transient fever 24–36 h after first IVIG infusion did not differ from that seen in responsive patients
Current management guidelines for patients with Kawasaki disease (KD) differ in their recommendations for fever observation times when determining resistance to initial intravenous immunoglobulin (IVIG). This retrospective study assessed coronary artery status in patients with transient fever 24–36 h after the completion of a first IVIG infusion. Children with KD treated with IVIG between January 2006 and February 2017 were included. Subjects were divided into three groups according to response following the completion of initial IVIG treatment (Group 1, no fever after 24 h; Group 2, transient fever at 24–36 h; Group 3, others). A total of 879 children were evaluated (Group 1, n = 663; Group 2, n = 54; Group 3, n = 162). During the subacute phase, the left main coronary artery (LMCA) diameter z score in both groups was significantly lower than that in Group 3 (Group 1: 1.02, Group 2: 0.87, Group 3: 1.24; Group 1 vs 2, P = 0.298; Group 1 vs 3, P = 0.025; Group 2 vs 3, P = 0.042); similar results were seen with the left anterior descending coronary artery (LAD) diameter z score (Group 1: 0.64, Group 2: 0.38, Group 3: 0.98; Group 1 vs 2, P = 0.083; Group 1 vs 3, P = 0.001; Group 2 vs 3, P = 0.004). The coronary artery (CA) status also did not differ between Groups 1 and 2 during the convalescent phase (z score of LMCA was 0.70 in Group 1 and 0.74 in Group 2, P = 0.790; z score of LAD was 0.42 and 0.46 respectively, P = 0.796; z score of right CA was 0.07 and 0.00 respectively, P = 0.630). A multivariate logistic regression analysis identified total bilirubin level (OR, 2.472; 95% CI, 1.284–4.762; P = 0.007) as the only significant predictor of persisting fever over 36 h in patients with fever 24 h after the completion of initial IVIG. The CA status of patients with transient fever 24–36 h after the first IVIG infusion did not differ from that seen in responsive patients.
- Open Access
- 1 January 2017
- Published by XMLink in Journal of Korean Medical Science
- Vol. 32 (3) , 457-464
Clinical Characteristics of Transplant-associated Encephalopathy in Children
Lee YJ, et al. J Korean Med Sci. 2017 Mar;32(3):457-464. https://doi.org/10.3346/jkms.2017.32.3.457
- 1 January 2017
- Published by XMLink in Journal of Korean Medical Science
- Vol. 32 (3) , 457-464
Open AccessClinical Characteristics of Transplant-associated Encephalopathy in Children
Lee YJ, et al. J Korean Med Sci. 2017 Mar;32(3):457-464. https://doi.org/10.3346/jkms.2017.32.3.457
- Open Access
- 1 January 2015
- Published by XMLink in Korean Circulation Journal
- Vol. 45 (3) , 216-224
Small Left Atrial Size Complicating Percutaneous Transcatheter Device Closure of Secundum Atrial Septal Defect with Conventional Approach
Ko HK, et al. Korean Circ J. 2015 May;45(3):216-224. https://doi.org/10.4070/kcj.2015.45.3.216
- 1 January 2015
- Published by XMLink in Korean Circulation Journal
- Vol. 45 (3) , 216-224
Open AccessSmall Left Atrial Size Complicating Percutaneous Transcatheter Device Closure of Secundum Atrial Septal Defect with Conventional Approach
Ko HK, et al. Korean Circ J. 2015 May;45(3):216-224. https://doi.org/10.4070/kcj.2015.45.3.216
- 15 July 2014
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 25 (1) , 129-136
Comparison of the offset distance of the tricuspid septal leaflet in neonates with Ebstein’s anomaly and neonates with pulmonary atresia with intact ventricular septum
An indexed offset distance of the tricuspid septal leaflet ⩾8 mm/m2is a quantitative criterion for the diagnosis of Ebstein’s anomaly. The purpose of this study was to investigate the validity of this criterion for the discrimination of Ebstein’s anomaly from pulmonary atresia with intact ventricular septum in neonatal patients. A total of 122 neonatal patients, 56 with Ebstein’s anomaly and 66 with pulmonary atresia with intact ventricular septum, were enrolled. Diagnosis of each anomaly was based on typical morphologic features. Echocardiographic variables, including the offset distance of the tricuspid septal leaflet, were measured via an offline analysis of images recorded before 1 month of age. The offset distance of the tricuspid septal leaflet was indexed by the body surface area, and the indexed offset distances in the Ebstein’s anomaly and pulmonary atresia with intact ventricular septum groups were 34.2 mm/m2(7.1–119.1 mm/m2) and 7.2 mm/m2(0.0–25.6 mm/m2), respectively. The indexed offset distance was ⩾8 mm/m2in 29 (43.9%) of the patients with pulmonary atresia with intact ventricular septum; clinical and echocardiographic characteristics were comparable between these 29 patients and the remaining 37 patients with pulmonary atresia with intact ventricular septum. When an indexed offset distance ⩾8 mm/m2was applied as a cut-off for the diagnosis of Ebstein’s anomaly, the sensitivity was 0.963 and the specificity was 0.561. In conclusion, indexed offset distance ⩾8 mm/m2cannot be used as a cut-off for the diagnosis of complicated Ebstein’s anomaly in neonatal patients with pulmonary atresia with intact ventricular septum.
- 15 July 2014
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 25 (1) , 129-136
Comparison of the offset distance of the tricuspid septal leaflet in neonates with Ebstein’s anomaly and neonates with pulmonary atresia with intact ventricular septum
An indexed offset distance of the tricuspid septal leaflet ⩾8 mm/m2is a quantitative criterion for the diagnosis of Ebstein’s anomaly. The purpose of this study was to investigate the validity of this criterion for the discrimination of Ebstein’s anomaly from pulmonary atresia with intact ventricular septum in neonatal patients. A total of 122 neonatal patients, 56 with Ebstein’s anomaly and 66 with pulmonary atresia with intact ventricular septum, were enrolled. Diagnosis of each anomaly was based on typical morphologic features. Echocardiographic variables, including the offset distance of the tricuspid septal leaflet, were measured via an offline analysis of images recorded before 1 month of age. The offset distance of the tricuspid septal leaflet was indexed by the body surface area, and the indexed offset distances in the Ebstein’s anomaly and pulmonary atresia with intact ventricular septum groups were 34.2 mm/m2(7.1–119.1 mm/m2) and 7.2 mm/m2(0.0–25.6 mm/m2), respectively. The indexed offset distance was ⩾8 mm/m2in 29 (43.9%) of the patients with pulmonary atresia with intact ventricular septum; clinical and echocardiographic characteristics were comparable between these 29 patients and the remaining 37 patients with pulmonary atresia with intact ventricular septum. When an indexed offset distance ⩾8 mm/m2was applied as a cut-off for the diagnosis of Ebstein’s anomaly, the sensitivity was 0.963 and the specificity was 0.561. In conclusion, indexed offset distance ⩾8 mm/m2cannot be used as a cut-off for the diagnosis of complicated Ebstein’s anomaly in neonatal patients with pulmonary atresia with intact ventricular septum.
- Open Access
- 1 January 2012
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 42 (12) , 823-829
Diagnosis of Incomplete Kawasaki Disease in Infants Based on an Inflammation at the Bacille Calmette-Guérin Inoculation Site
Seo JH, et al. Korean Circ J. 2012 Dec;42(12):823-829. https://doi.org/10.4070/kcj.2012.42.12.823
- 1 January 2012
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 42 (12) , 823-829
Open AccessDiagnosis of Incomplete Kawasaki Disease in Infants Based on an Inflammation at the Bacille Calmette-Guérin Inoculation Site
Seo JH, et al. Korean Circ J. 2012 Dec;42(12):823-829. https://doi.org/10.4070/kcj.2012.42.12.823
- Open Access
- 1 January 2012
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 42 (1) , 40-45
Effectiveness and Safety of Percutaneous Transcatheter Implantation of Pulmonary Arterial Stent in Congenital Heart Disease
Ko HK, et al. Korean Circ J. 2012 Jan;42(1):40-45. https://doi.org/10.4070/kcj.2012.42.1.40
- 1 January 2012
- Published by The Korean Society of Cardiology in Korean Circulation Journal
- Vol. 42 (1) , 40-45
Open AccessEffectiveness and Safety of Percutaneous Transcatheter Implantation of Pulmonary Arterial Stent in Congenital Heart Disease
Ko HK, et al. Korean Circ J. 2012 Jan;42(1):40-45. https://doi.org/10.4070/kcj.2012.42.1.40